New drug may offer hope for treating thyroid cancer

Nov 29, 2010

A new drug may help treat thyroid cancer patients

There are many benefits to purchasing life insurance early in life. One main benefit is the lower life insurance premiums younger people typically get because of their overall better health. A person cannot predict when they may come down with a condition that can ultimately lead rates to increase.

One such condition is cancer. There are more than 44,600 diagnosis of thyroid cancer alone in the U.S. per year, according to the National Cancer Institute. More than 1,600 lose their battle with the disease each year.

Researchers from the Mayo Clinic have found that target therapy with a drug called pazopanib decreases the growth rate of the cancer with aggressive forms of the disease. However, researcher and medical oncologist Dr. Keith Bible says more research needs to be performed.

"Further studies of pazopanib in advanced thyroid cancer remain ongoing at Mayo Clinic and associated cancer centers to continue to learn more about how best to use the drug in these cancers," says Bible. "Such clinical trials also may provide patients access to this drug, which otherwise may be unobtainable due to cost, given that it is not yet approved for use in thyroid cancers."

As with many conditions, it's not clear what causes thyroid cancer.

< Back

Follow Efinancial

Free Life Insurance Quotes

Zip Code



Height/Weight (lbs.)



Gender